7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one
C19H22FN3O2 — CID 153399950
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one
7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one (PubChem CID 153399950) has the molecular formula C19H22FN3O2 and a molecular weight of 343.40 g/mol. Its IUPAC name is 7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one.
Molecular Properties
| Compound Name | 7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one |
|---|---|
| PubChem CID | 153399950 |
| Molecular Formula | C19H22FN3O2 |
| Molecular Weight | 343.40 g/mol |
| Exact Mass | 343.17 |
| IUPAC Name | 7-[4-(2-fluorophenyl)-2,3-dihydro-1H-imidazol-2-yl]-1-(1,2-oxazol-3-yl)heptan-1-one |
| SMILES | O=C(CCCCCCC1NC=C(c2ccccc2F)N1)c1ccon1 |
| InChI | InChI=1S/C19H22FN3O2/c20-15-8-6-5-7-14(15)17-13-21-19(22-17)10-4-2-1-3-9-18(24)16-11-12-25-23-16/h5-8,11-13,19,21-22H,1-4,9-10H2 |
| InChIKey | RKZUNAQITMUAJV-UHFFFAOYSA-N |
| XLogP | 3.85 |
| TPSA | 67.16 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 343.40 |
| LogP ≤ 5 | 3.85 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153399950 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.